SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 237 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $486,000 | +27.9% | 20,502 | -3.0% | 0.07% | -2.9% |
| Q1 2020 | $380,000 | -46.3% | 21,127 | -29.2% | 0.07% | -33.7% |
| Q4 2019 | $708,000 | -34.0% | 29,850 | -23.5% | 0.10% | -40.9% |
| Q3 2019 | $1,072,000 | -28.1% | 39,023 | -13.3% | 0.18% | -29.9% |
| Q2 2019 | $1,490,000 | -4.7% | 45,033 | +0.9% | 0.25% | -8.1% |
| Q1 2019 | $1,563,000 | +24.7% | 44,613 | +18.2% | 0.27% | +5.4% |
| Q4 2018 | $1,253,000 | -40.2% | 37,739 | -9.3% | 0.26% | -31.7% |
| Q3 2018 | $2,096,000 | – | 41,630 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |